Investor updates

Investor updates.

Investor Update - February 2024

February 21st 2024
investor updates

Investor Update - August 2023

August 18th 2023
investor updates

Investor Update - November 2022

November 17th 2022
investor updates

Analyst reports

Analyst reports.

Ladenburg Thalmann - Next Is Dose Optimization for BC Program; Reiterate Buy, $8.30 PT (Analyst: Ahu Demir, PhD)

For a copy of this research report please contact your Ladenburg Thalmann advisor

March 6th 2024
analyst reports

Baird - First Data on Highest Dose Ever of Efti Includes a Complete Response; Rated Outperform, $7 tgt (Analyst: Joel L. Beatty, MD, CFA)

For a copy of this research report please contact your Baird advisor

March 6th 2024
analyst reports

Wilsons - Dose it higher? Now an option; Mtn Overweight, A$0.90 Tgt (Analysts: Dr Melissa Benson and Dr Shane Storey)

March 5th 2024
analyst reports


E-MAIL UPDATES

registration.

Please fill out the registration form below to receive updates and announcements by e-mail.